Company page

Bioxcel Therapeutics, Inc.

Bioxcel Therapeutics, Inc. (BTAI) is a public company based in the United States with a market capitalization of approximately $37 million. The company focuses on developing innovative therapies to improve patient outcomes in various medical conditions. Bioxcel is committed to advancing its research and development efforts in the biopharmaceutical sector.